Reporting Manager
Ardsley Advisory Partners LP
Symbol
ASBP
Shares outstanding
138,530,928 shares
Disclosed Ownership
10,750,000 shares
Ownership
7.8%
Form type
SCHEDULE 13G
Filing time
12 Feb 2026, 13:00:30 UTC
Date of event
31 Dec 2025

Sponsored

Quoteable Key Fact

"ARDSLEY ADVISORY PARTNERS LP disclosed 7.8% ownership in Aspire Biopharma Holdings, Inc. Common Stock (ASBP) on 31 Dec 2025."

Quick Takeaways

  • ARDSLEY ADVISORY PARTNERS LP filed SCHEDULE 13G for Aspire Biopharma Holdings, Inc. Common Stock (ASBP).
  • Disclosed ownership: 7.8%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 12 Feb 2026, 13:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Ardsley Advisory Partners LP 7.8% 10,750,000 0 10,750,000 /s/ Steve Napoli Steve Napoli/ Member
Ardsley Advisory Partners GP LLC 7.8% 10,750,000 0 10,750,000 /s/ Steve Napoli Steve Napoli/ Member
Ardsley Partners I GP LLC 7.8% 10,750,000 0 10,750,000 /s/ Steve Napoli Steve Napoli/ Member
Ardsley Partners Advanced Healthcare Fund, L.P. 6.7% 9,229,100 0 9,229,100 /s/ Steve Napoli Steve Napoli/ Member
Ardsley Partners Fund II, L.P. 1.1% 1,520,900 0 1,520,900 /s/ Steve Napoli Steve Napoli/ Member
Philip J. Hempleman 7.8% 10,750,000 0 10,750,000 /s/ Steve Napoli* Steve Napoli/Attorney-in Fact for Philip J. Hempleman